News

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a 10-year low ...
The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...
The decision had been expected by April 1, but the agency now says it needs more information before moving forward.
Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...
More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...
Alzheimer’s disease is notorious for robbing individuals of memory and cognitive function. Researchers have struggled for ...
(Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services ...
Shortly after Donald Trump picked Robert F. Kennedy Jr. to lead his health department, a group of pharmaceutical executives ...
Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...